Paris-based biotechnology company developing gene therapy treatments for orphan diseases, with a focus on liver-targeted therapies that correct malfunctioning genes
Paris-based biotechnology company developing gene therapy treatments for orphan diseases, with a focus on liver-targeted therapies that correct malfunctioning genes. Its pipeline includes treatments for conditions such as Wilson disease and progressive familial intrahepatic cholestasis type 2.